Back to Screener

Healthcare

UroGen Pharma Ltd.(URGN)

Live Price

Offline

$33.57

+2.32% today

1Y Change

+134.76%

Window

Jun 23, 2025 โ†’ Jun 18, 2026

Market Cap
$1.12B
Revenue Growth
+21.4%
EPS Growth
-7.8%
Dividend Yield
0.0%

Coverage: 249 bars ยท Jun 23, 2025 โ†’ Jun 18, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

UroGen Pharma Ltd. (URGN) is a Healthcare stock with a market cap of $1.12B and listed on NASDAQ. The stock last traded around $33.57 and up 134.8% across the available one-year price window (Jun 23, 2025 โ†’ Jun 18, 2026). Baseline metrics include revenue growth of +21.4%, EPS growth of -7.8%, a dividend yield of 0.0%. What stands out right now is revenue +21.4%, EPS -7.8%, free cash flow -67.7% with operating margin -113.7% and ROIC -81.1%. Valuation already assumes a fairly strong business story at price/sales 10.2. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines URGN price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Comparison

Normalized Performance vs SPY

Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.

1Y shared range

URGN

โ€”

Normalized return

SPY

โ€”

S&P 500

Excess Return

โ€”

Relative to SPY

URGN Max Drawdown

-42.22%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for URGN and SPY.

Calendar-year return history is still loading or unavailable.

Earnings Reports

๐Ÿ“… Last reportedMay 11, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”Report
โ€”
May 11, 26
โ€”
Est -0.50
โ€”
โ€”
Est 44464.7B
โ€”
May 11
โ€”
Mar 2, 26
โœ—
-0.54
Est -0.52
-4.3%
37837.0B
Est 39914.3B
-5.2%
Mar 2
โ€”
Nov 6, 25
โœ“
-0.69
Est -0.72
+4.2%
27482.0B
Est 40134.9B
-31.5%
Nov 6
โ€”
Aug 7, 25
โœ—
-1.05
Est -0.82
-28.1%
24215.0B
Est 33569.9B
-27.9%
Aug 7
โ€”
May 12, 25
โœ—
-0.92
Est -0.83
-10.8%
20254.0B
Est 23262.0B
-12.9%
May 12
โ€”
Mar 10, 25
โœ—
-0.80
Est -0.69
-15.9%
24565.0B
Est 23341.8B
+5.2%
Mar 10
โ€”
Nov 6, 24
โœ“
-0.55
Est -0.84
+34.5%
25204.0B
Est 26133.3B
-3.6%
Nov 6
โ€”
Aug 13, 24
โœ—
-0.91
Est -0.82
-11.0%
21848.0B
Est 23960.0B
-8.8%
Aug 13
โ€”
May 13, 24
โœ—
-0.97
Est -0.93
-4.3%
18781.0B
Est 21380.0B
-12.2%
May 13
โ€”
Mar 14, 24
โœ—
-0.72
Est -0.67
-7.5%
23530.0B
Est 22570.0B
+4.3%
Mar 14
โ€”
Nov 14, 23
โœ“
-0.68
Est -0.89
+23.6%
20852.0B
Est 22570.0B
-7.6%
Nov 14
โ€”
Aug 10, 23
โœ“
-1.03
Est -1.13
+8.8%
21139.0B
Est 20120.0B
+5.1%
Aug 10
โ€”
May 11, 23
โœ“
-1.30
Est -1.39
+6.5%
17192.0B
Est 17180.0B
+0.1%
May 11
โ€”
Mar 16, 23
โœ—
-1.22
Est -1.12
-8.9%
18092.0B
Est 18510.0B
-2.3%
Mar 16
โ€”
Nov 10, 22
โœ“
-1.13
Est -1.22
+7.4%
16097.0B
Est 20145.5B
-20.1%
Nov 10
โ€”
Aug 11, 22
โœ“
-1.18
Est -1.33
+11.3%
16604.0B
Est 17224.0B
-3.6%
Aug 11
โ€”
May 10, 22
โœ“
-1.25
Est -1.36
+8.1%
13564.0B
Est 15172.3B
-10.6%
May 10
โ€”
Mar 21, 22
โœ—
-1.27
Est -1.18
-7.6%
16174.0B
Est 16243.3B
-0.4%
Mar 21
โ€”
Nov 15, 21
โœ—
-1.35
Est -1.26
-7.1%
11351.0B
Est 15420.0B
-26.4%
Nov 15
โ€”
Aug 4, 21
โœ—
-1.17
Est -1.10
-6.4%
13032.0B
Est 13032.0B
0.0%
Aug 4
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.

Read the earnings calendar guideOpen the calendar screener